scorecardresearch
Add as a preferred source on Google
Wednesday, December 3, 2025
TopicAstraZeneca

Topic: AstraZeneca

AstraZeneca trial illness likely not linked to Covid vaccine, Oxford says

After safety reviews, Oxford says there is insufficient evidence to say for certain that neurological symptoms developed by volunteers were or were not related to the vaccine.

Serum Institute to resume trials of AstraZeneca’s Covid vaccine after DCGI nod

AstraZeneca said clinical trials for the AstraZeneca Oxford Covid vaccine had resumed in UK following confirmation by the Medicines Health Regulatory Authority that trials were safe.

AstraZeneca restarts UK trials of Oxford vaccine

Oxford said the UK health regulator approved resuming the trials after review of the safety data triggered a pause on 6 September. It declined to disclose details about the participant’s illness.

Still aiming for Oxford Covid vaccine by end of this year, AstraZeneca CEO says

AstraZeneca CEO Pascal Soriot sought to reassure investors after the Oxford vaccine trial was halted due to a person in the UK falling sick, triggering a review of safety data.

Delay of AstraZeneca’s Covid vaccine could be painful but it’s responsible

The AstraZeneca Plc paused the trial of its leading candidate, developed with Oxford University, to study a volunteer's illness. This pause shows the system is working as it should.

AstraZeneca must explain spinal ailment in UK for Covid vaccine trial to resume

If AstraZeneca’s review finds spinal ailment in UK patient is related to Covid vaccine, all doses already manufactured will be thrown away.

Drug regulator sends notice to Serum Institute over AstraZeneca vaccine trial

DCGI issued a show-cause notice to Serum Institute following reports that human trials of the Oxford vaccine were paused in UK after a candidate had an adverse reaction.

AstraZeneca vaccine setback is a reality check in the race to find protection from Covid

In a world crippled by Covid, the AstraZeneca vaccine setback comes as reminder that vaccines can fail or can sometimes deliver more harm than good.

Oxford Covid vaccine trial paused after unexplained illness, AstraZeneca says it’s ‘routine’

Suspension of the trial is a routine action whenever there is a potentially unexplained illness to ensure we maintain integrity of trials, AstraZeneca says.

Oxford vaccine human trial in India a step closer as panel clears Serum Institute protocol 

The protocol will now be moved to DCGI V.G. Somani, who is likely to take a ‘decision by the end of the week’ given the urgency of the Covid challenge.

On Camera

The politics of air pollution—how they are fooling the citizens

Greens have a sizeable support in the Western countries with clean air and blue skies, but not in India, where poisonous air, water and soil kill millions.

India’s Insolvency & Bankruptcy Code is struggling to deliver. It’ll take a decade to clear backlog

The Centre is considering an increase in the National Company Law Tribunal's bench capacity, while the Standing Committee of Finance suggests fast-track courts. 

India to commission new squadron of submarine-hunting Romeo choppers in Goa later this month

The helicopters produced by Lockheed Martin are known as ‘submarine hunters’. India ordered 24 of these aircraft in 2020 to replace the Sea King helicopters. 15 have been delivered till date.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.